Maintenance bacillus Calmette-Guérin for non-muscle-invasive bladder cancer: do we finally know the best schedule?
- PMID: 23177081
- DOI: 10.1016/j.eururo.2012.11.023
Maintenance bacillus Calmette-Guérin for non-muscle-invasive bladder cancer: do we finally know the best schedule?
Comment on
-
Final results of an EORTC-GU cancers group randomized study of maintenance bacillus Calmette-Guérin in intermediate- and high-risk Ta, T1 papillary carcinoma of the urinary bladder: one-third dose versus full dose and 1 year versus 3 years of maintenance.Eur Urol. 2013 Mar;63(3):462-72. doi: 10.1016/j.eururo.2012.10.039. Epub 2012 Nov 2. Eur Urol. 2013. PMID: 23141049 Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
